Ru Nimo horizon continuous infusion treatment of cerebral vasospasm after subarachnoid hemorrhage Efficacy of_0.doc

 PAGE \* MERGEFORMAT 7 Ru Nimo horizon continuous infusion treatment of cerebral vasospasm after subarachnoid hemorrhage Efficacy of Of: Qi Wenjun, Zhang Yi, Luo Heng Qin, Zhang Ning [Abstract] Objective To investigate the horizon continued to pump Ru Nimo vasospasm after subarachnoid hemorrhage control effect. Methods 53 patients with subarachnoid hemorrhage were randomly divided into treatment group and control group were observed in the conventional therapy group continued to pump Ru Nimo horizon, the control group underwent conventional treatment, oral nimodipine tablets. Comparison of continuous infusion and the efficacy of oral nimodipine. Results In both groups the incidence of cerebral vasospasm in patients with significant differences was statistically significant effect of the observation group better than the control group. Conclusion horizon continuous infusion Ru Nimo prevention and treatment of cerebral vasospasm after subarachnoid hemorrhage significant effect. [Keywords:] nimodipine; cerebral vasospasm Subarachnoid hemorrhage prevention of oral nimodipine (subarachnoid hemorrhage, SAH) cerebral vasospasm (CVS), widely used in clinical practice [1]. Continued to pump Ru Nimo horizon is more effective, is not yet sure. The study concluded in our hospital from March 2006 to January 2009 were treated 53 patients with subarachnoid hemorrhage, compared with continuous infusion into the prevention and treatment of oral nimodipine CVS results, are as follows. 1 Materials and Methods 1.1 General information on this group 53 patients with primary SAH, including 38 males and 15 females, aged 18 to 63 years, mean 44 years old. Clinical manifestations were headache, vomiting, meningeal irritation, including 17 cases of drowsiness, coma varying degrees of consciousness and 5 patients had focal limb paralysis and other neurological signs. All the cases are in line with the Chinese Medical Association to determine the fourth session of cerebro